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Abstract
With the rapid growth of modern technology, many large-scale
biomedical studies have been/are being/will be conducted to collect
massive datasets with large volumes of multi-modality imaging, ge-
netic, neurocognitive, and clinical information from increasingly large
cohorts. Simultaneously extracting and integrating rich and diverse
heterogeneous information in neuroimaging and/or genomics from these
big datasets could transform our understanding of how genetic variants
impact brain structure and function, cognitive function, and brain-
related disease risk across the lifespan. Such understanding is crit-
ical for diagnosis, prevention, and treatment of numerous complex
brain-related disorders (e.g., schizophrenia and Alzheimer’s disease).
However, the development of analytical methods for the joint analysis
of both high-dimensional imaging phenotypes and high-dimensional
genetic data, referred to as big data squared (BD2), presents major
computational and theoretical challenges for existing analytical meth-
ods. Besides the high-dimensional nature of BD2, various neuroimag-
ing measures often exhibit strong spatial smoothness and dependence
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and genetic markers may have a natural dependence structure arising
from linkage disequilibrium. We review some recent developments of
various statistical techniques for the joint analysis of BD2, including
massive univariate and voxel-wise approaches, reduced rank regres-
sion, mixture models, and group sparse multi-task regression. By do-
ing so, we hope that this review may encourage others in the statistical
community to enter into this new and exciting field of research.
1 INTRODUCTION
Despite the numerous successes of genome-wide association studies (GWAS),
it has been difficult to unravel the genetic basis of many complex neurological
diseases since each genetic variant may only contribute in a small way to
disease risk and such a genetic basis can be very heterogeneous (Cannon
and Keller, 2006; Marenco and Radulescu, 2010; Peper, et al. 2007). The
additive and interactive effects of perhaps hundreds of risk genes and multiple
environmental risk factors, each with small individual effects, may contribute
to the abnormal developmental trajectories that underlie neurological and
psychiatric disorders such as Alzheimer’s Disease. Identifying such risk genes
and environmental risk factors could transform our understanding of the
origins of these conditions and inspire new approaches for urgently needed
preventions, diagnoses, and treatments. Once such an identification has been
accomplished, lifestyle and medical interventions can be applied to make a
potential difference in the outcome.
A promising approach to understanding the genetic basis of neurolog-
ical disorders is through studies that integrate multi-scale data from ge-
netic/genomic, multimodal brain imaging, and environmental risk factors
(Hibar, et al., 2011; Thompson, et al., 2013; Hibar, et al., 2015), so called
imaging genetics studies.
To promote such studies, the Brain Imaging Clinical Research Program
at the National Institute of Mental Health (NIMH) has called for the estab-
lishment of relationships between genetic variations and imaging and cog-
nitive findings and phenotypes in adult mental disorders. To this end, a
number of large-scale publicly available imaging genetic databases have been
established, including the Human Connectome project (HCP) study, the UK
biobank (UKbb) study, the Pediatric Imaging, Neurocognition, and Genet-
ics (PING) study, the Philadelphia Neurodevelopmental Cohort (PNC), and
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the Alzheimer’s Disease Neuroimaging Initiative (ADNI) study, among many
others. The ADNI database in particular has been used extensively by statis-
ticians working on the development of methods for the joint analysis of neu-
roimaging and genetic data, and this database serves as a good starting point
for new researchers in the area.
In such studies, the data available for each subject may include multiple
MRI images, such as structural MRI, diffusion tensor imaging (DTI), and
functional MRI, cognitive assessments, and genomic data (e.g., SNP array
and copy number variations (CNVs)). Jointly analyzing imaging genetics
with clinical variables, however, raises serious challenges as existing statistical
methods are rendered infeasible for efficiently analyzing large-scale imaging
genetic data sets with many subjects. These challenges arise from a setting
where the data involve high-dimensional imaging data × high-dimensional
genetic data – so-called Big Data squared (BD2), complex correlation and
spatial structures within both imaging and genetic data, and a potentially
large number of subjects.
For many brain-related diseases, since changes in brain structure and
function are very subtle, it is common to normalize multi-modal neuroimag-
ing data to a common template (Xu, et al., 2003; Miller and Younes, 2001).
After normalization, various imaging phenotypes are commonly calculated
from structural and functional imaging data (Friston, 2009; Zhu, et al., 2007).
These normalized neuroimaging phenotypes are functional data measured at
a very large number (104 − 107) of grid points along space and/or time and
network data measured among a large number (104−106) of region of interest
(ROI) pairs (Hibar, et al., 2011; Thompson, et al., 2013; Hibar, et al., 2015;
Ge, et al., 2015a, 2015b). See Figure 1 for a graphical depiction of potential
Imaging Phenotypes (IPs).
The earliest methods developed for imaging genetics data analysis are
either based on significant reductions to both data types, for example, re-
stricting the analysis to a specific candidate ROI in the brain and/or a specific
candidate genetic marker. This type of univariate analysis can be extended
to handle full brain-wide genome-wide data based on the application of a
massive number of pairwise univariate analyses, each based on a standard
linear regression relating a given voxel/region to a given SNP. In this case
the multiple testing problem can be on a very large scale and the resulting
corrections very stringent, given the large number of tests involved. For ex-
ample, in a full brain-wide genome-wide study involving 106 known genetic
variants and 106 locations in the brain, this type of analysis will require 1012
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univariate analyses. Furthermore, the resulting p-values are not independent
because of spatial correlation in the imaging data.
Stein et al. (2010) are the first to consider such an analysis and these
authors examined 448, 293 SNPs in each of 31, 622 voxels of the entire brain
across 740 elderly subjects with 300 computational-cluster nodes used to
carry out the required computations in parallel. Hibar et al. (2011) consider
a similar analysis but reduce the number of tests by conducting the analysis at
the gene rather than SNP level. In this case principal component analysis is
used to summarize the SNP data for each gene, and the resulting ‘eigenSNPs’
are used in the massive univariate analysis.
As an alternative to the massive univariate approach, a voxel-wise ap-
proach continues to fit regression models separately at each location in the
brain, but considers a set of genetic markers simultaneously rather than just
a single genetic marker. Ge et al. (2011) develop such an analysis and exam-
ine a dataset that is similar to that considered in Stein et al. (2010), but a
key difference is the use of a multi-locus model based on least squares kernel
machines (Liu et al., 2007), which is used to combine the effect of multiple
genetic variants and model their interaction. In addition, the spatial infor-
mation in the images is accounted for through the use of random field theory
as an inferential tool (Worsley, 2002). This approach is extended in Ge et
al. (2015) to allow for potential interactions between genetic variables and
non-genetic variables such as disease-risk factors, environmental exposures,
and epigenetic markers.
An alternative fast voxel-wise genome-wide association analysis (FVG-
WAS) approach is that developed by Huang et al. (2015) where the authors
focus on reducing the computational burden required for a full brain-wide
gene-wide study. This objective is implemented in part by incorporating
a global sure independence screening procedure along with inference based
on the wild bootstrap. The resulting approach can implement a brain-wide
genome-wide analysis in a relatively small amount of time utilizing only a
single CPU.
One drawback of the massive univariate and voxel-wise approaches is
that the relationship between the different neuroimaging phenotypes (e.g.
at different regions of the brain) is not explicitly modelled, and therefore,
potential efficiency gains arising from the borrowing of information across
brain regions are not realized. An alternative approach is to base the analysis
on a single large model, a multivariate high-dimensional regression model
that is fit to the entire dataset. In this framework the scale of the data must
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necessarily be reduced, and it is common to summarize the entire image using
a relatively moderate number of brain summary measures across some key
ROIs. As an example, Table 1 describes a phenotype of dimension 56 that
can be derived from an MRI image, and these data are considered in our
example application.
One such regression model is the group-sparse multitask regression model
proposed by Wang et al. (2012) where estimation of the regression coeffi-
cients in a multivariate linear model is based on penalized least squares. The
penalty is chosen to induce a particular form of structured sparsity in the
solutions based on two nested forms of group sparsity. The first is at the
SNP level (grouping the regression coefficients of a given SNP across all phe-
notypes) and the second is at the gene level, which groups all SNPs within
a given gene. More recently, Greenlaw et al. (2017) have extended this ap-
proach to the Bayesian setting which allows for inference and uncertainty
quantification for the regression coefficients of the selected genetic markers.
An alternative multivariate approach is based on approximating the high-
dimensional regression coefficient matrix with a low rank matrix. Such an
approach has been developed by Vounou et al. (2010), who develop a sparse
reduced-rank regression (SRRR) model which is applied to an imaging genet-
ics study involving 111 anatomical ROIs and 437, 577 SNPs. Using simulation
studies Vounou et al. (2010) show that their SRRR model has higher power
to detect deleterious genetic variants compared with the massive univariate
approach. Along similar lines, Zhu et al. (2014) also develop a low rank
regression model with inference conducted in the Bayesian framework and
they apply their approach to an imaging genetics study involving 93 ROIs and
1, 071 SNPs. Also in the Bayesian framework, Stingo et al. (2013) develop
a hierarchical mixture model for relating brain connectivity to genetic infor-
mation for studies involving functional magnetic resonance imaging (fMRI)
data. The mixture components of the proposed model are used to classify
the study subjects into subgroups, and the allocation of subjects to these
mixture components is linked to genetic markers with regression parameters
assigned spike-and-slab priors. The proposed model is used to examine the
relationship between functional brain connectivity based on fMRI data and
genetic variation.
Huang et al. (2017) developed a functional genome-wide association anal-
ysis (FGWAS) framework to efficiently carry out whole-genome analyses of
functional phenotypes. Compared with FVGWAS, FGWAS explicitly mod-
els the functional features of functional phenotypes through the integration
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of smooth coefficient functions and functional principal component analysis.
Statistically, compared with existing methods for genome-wide association
studies (GWAS), FGWAS can substantially boost the detection power for
discovering important genetic variants influencing brain structure and func-
tion.
In more recent work, researchers have turned their attention to longitu-
dinal imaging genetics studies where study subjects are followed over time
with neuroimaging data collected over a sequence of time points during a
follow-up period. With longitudinal MRI data, changes in the structure of
the brain over time can be characterized, for example, by examining rates
of brain deterioration, and these estimated rates of change can be related to
genetic markers. Szefer et al. (2017) examine the presence of linear asso-
ciation between minor allele counts of 75, 845 SNPs in the Alzgene linkage
regions and estimated rates of change of structural MRI measurements for 56
brain regions. The authors develop a bootstrap-enhanced sparse canonical
correlation analysis to create refined lists of SNPs associated with rates of
structural change over time.
Lu et al. (2017) develop a Bayesian approach to perform longitudi-
nal analysis of multivariate neuroimaging phenotypes and candidate genetic
markers obtained from longitudinal studies. A low rank longitudinal regres-
sion model is specified where penalized splines are incorporated to charac-
terize an overall time effect, and a sparse factor analysis model coupled with
random effects is proposed to account for spatiotemporal correlations of lon-
gitudinal phenotypes. A useful feature of the proposed methodology is the
allowance for interactions between genetic main effects and time.
In the remainder of the paper, Sections 2 - 4 discuss in more detail some of
the methods mentioned above, with emphasis placed on our own work. Sec-
tion 5 presents an example application where data from the ADNI-1 database
are used to examine the association between the 56 neuroimaging phenotypes
presented in Table 1 and a collection of 486 SNPs from 33 genes belonging to
the top 40 Alzheimer’s Disease (AD) candidate genes listed on the AlzGene
database as of June 10, 2010. Section 6 concludes with a discussion of some
ongoing work in this area.
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2 Mass Univariate and Voxel-Wise Approaches
Mass univariate approaches avoid the complication of jointly modelling all
neuroimaging phenotypes and genetic markers and simply conduct a test
for association at each possible pair of voxel and genetic marker. Voxel-
wise approaches are similar in that a separate model is fit independently at
each voxel of the image, but these approaches may include multiple genetic
markers in each model. The primary advantage of these approaches is that
they make feasible a full brain-wide and genome-wide search for associations.
We assume that neuroimaging and genetic data are available on n sub-
jects, where the imaging phenotype is denoted as y`(v), for the numerical
value of the brain image of subject `, ` = 1, . . . , n, at voxel v, v = 1, . . . , V .
We denote the set of genetic markers for subject l by x` = (x`1, . . . , x`d)
T , ` =
1, . . . , n, for a total of d markers, where x`j ∈ {0, 1, 2} is the number of copies
of the minor allele for the jth SNP, which takes values x`j = 0 (homozygotic
major alleles), x`j = 1 (heterozygote), and x`j = 2 (homozygotic minor alle-
les). Finally, we let z` = (z`1, . . . , z`p)
T , ` = 1, . . . , n, denote a collection of
non-genetic variables for subject l.
Stein et al. (2010) is the first voxel-wise genome-wide association study
(vGWAS) examining genetic influence on brain structure. The authors con-
sider neuroimaging and genetic data obtained from n = 818 subjects as
part of the ADNI. The neuroimaging data are based on brain MRI scans
that are processed using an approach known as tensor-based morphometry
(TBM). TBM (Ashburner et al., 2000) is used to create images representing
volumetric tissue differences at each of approximately 31, 000 voxels for each
individual, where the value of the image in a given voxel is obtained by calcu-
lating the determinant of the Jacobian matrix of a deformation that encodes
local volume excess or deficit relative to an image that is representative of the
sample known as the mean template image. The analysis relates the value
of the image at each voxel to each of 448, 293 SNPs.
The statistical methodology considered by Stein et al. (2010) is fairly
straightforward, though the resulting computation is still extensive due to
the total number of tests considered. At each voxel v, a linear regression is
conducted with response y`(v) (volumetric tissue difference relative to a mean
template image at voxel v) and a separate regression model is fit relating this
response to each SNP x`j, assuming an additive genetic model. Additional
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independent variables age and gender are also included in the model,
y`(v) = β0 + β1Age` + β2Gender` + αx`j + e`(v, j).
A standard p-value from this linear regression is obtained for each SNP-voxel
pair (corresponding to a null hypothesis of α = 0), and these p-values are
computed at a given voxel as the model is fit repeatedly to all d SNPs.
To conserve memory, Stein et al. (2010) only save the minimum p-value
at each voxel. Under the null hypothesis that the phenotype at a given
voxel is not associated with any of the genetic markers, the minimum p-
value computed at each voxel is not uniform[0, 1], but it is shown to be
approximately Beta(1,Meff ), with Meff < M , where Meff is the effective
number of independent tests conducted at each voxel, and M is the total
number of genetic markers. The inequality Meff < M arises as a result of
linkage disequilibrium.
Stein et al. (2010) set the value of Meff equal to the number of prin-
cipal components required to jointly explain 99.5% of the variance in the
SNPs. The Beta(1,Meff ) distribution is used to correct the minimum p-
value computed at each voxel via the probability integral transform so that
the corrected minimum p-value is approximately distributed as uniform[0, 1].
False Discovery Rate (FDR) procedures are then applied to adjust for multi-
ple testing across voxels. Under the proposed scheme the computations can
be carried out in parallel across voxels, and Stein et al. (2010) employ 300
cluster nodes with a reported 27 hours of total computation time.
Hibar et al. (2011) develop a gene-based association method to com-
plement single-marker GWAS for implicating underlying genetic variants in
complex traits and diseases. The authors focus more broadly on gene-based
approaches as they can be more powerful than traditional SNP-based ap-
proaches, with the relative power depending on how the genetic variants af-
fect the phenotype. For example, if a gene contains multiple causal variants
with small individual effects, SNP-based methods may miss these associa-
tions if a very stringent significance threshold is used. Gene-based tests also
reduce the effective number of statistical tests by aggregating multiple SNP
effects into a single test statistic.
In Hibar et al. (2011) the SNP data are grouped by gene and SNPs that
are not located in a gene are excluded. Considering a dataset of the same
scale, both in terms of imaging and genetics, as that considered in Stein et al.
(2010), after grouping SNPs a total of 18, 044 genes are left for analysis. The
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authors propose a gene-based association method that is based on principal
components regression. Principal component analysis (PCA) is performed on
the SNP data within each gene, storing all of the orthonormal basis vectors of
the SNP matrix that explain a majority of the variance in the set of SNPs for
a given gene. Basis vectors with the highest eigenvalues (higher proportions
of explained variance) are included until 95% of the SNP variability within
the gene is explained, and the rest are discarded. The resulting ‘eigenSNPs’
approximate the information in the collection of observed SNPs for a given
gene.
Hibar et al. (2011) apply their approach by examining associations be-
tween 18, 044 genes and approximately 31, 000 voxel-specific phenotypes. At
each voxel, a multiple partial-F test is employed to test the the joint effect of
all eigenSNPs for a given gene on the value of the image (volume difference)
at the given voxel. The test is applied to all genes and the minimum p-value
is recorded at each voxel. Inference then proceeds using an approximate
Beta null distribution with FDR procedures applied to adjust for multiple
testing as in Stein et al. (2010). The required computation across all voxels
is parallelized over a cluster of 10 high performance 8-core CPU nodes and
Hibar et al. (2011) report that the total time required to complete an anal-
ysis with their computational setup is approximately 13 days. Summarizing
the SNP information in this way may have some disadvantages as well. In
particular, if a single SNP has a large main effect, then testing the joint
effect of all SNPs within that gene may dilute this association. However,
when one considers the drastic reduction in the number of independent tests
when comparing SNP-based linear regression with gene-specific summaries
based on PCA, gene-based testing offers advantages when dealing with an
extremely large number of voxels in an image phenotype.
In more recent work, Huang et al. (2015) have developed a fast voxel-wise
genome-wide association analysis with an emphasis on large-scale imaging
and genetic data. A key advantage of this methodology over the methods
developed by Stein et al. (2010) and Hibar et al. (2011) is that it requires
considerably less computational resources and is feasible to run on just a
single CPU with reasonable processing time. The proposed approach is based
on three main components: (1) a heteroscedastic linear model is specified at
each voxel-locus pair; (2) a global sure independence screening procedure
is incorporated to eliminate many noisy loci; (3) inference is based on wild
bootstrap methods. The heteroscedastic linear model at voxel v and locus c
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takes the form
y`(v) = z
T
` β(v) + x`cα(c, v) + e`(v), ` = 1, . . . , n
and the model makes no strong assumptions on V ar[e`(v)], in particular, it
may vary across subjects. The hypothesis test of interest is
H0(c, v) : α(c, v) = 0 versus H1(c, v) : α(c, v) 6= 0 for each (c, v).
Huang et al. (2015) introduce a standard Wald statistic W (c, v) that
is based on the ordinary least squares estimate of α(c, v). Under the het-
eroscedastic assumption of the regression model the standard approximations
based on the χ21 (or F ) distribution to the null distribution of W (c, v) do not
apply and a wild bootstrap method is proposed as an alternative. Huang
et al. (2015) then focus on approximations that make such a procedure
computationally feasible.
A key aspect of these approximations is that a global sure independence
screening procedure is used to eliminate many noisy loci. The global aspect of
the screening procedure reduces the set of SNPs for all voxels simultaneously.
The authors define a global Wald statistic W (c) for a given locus as the
average of W (c, v) taken over all voxels in the image. If, for a given locus c,
it is the case that H0(c, v) holds for all voxels v, then Huang et al. (2015)
argue that W (c, v) asymptotically converges to a weighted χ2 distribution.
The corresponding p-values are then computed for each locus c, and the top
N0 loci (e.g. N0 = 1000) are selected as the candidate set.
Given the candidate set, a wild bootstrap approach is applied to deter-
mine significant voxel-locus pairs, or alternatively, significant cluster-locus
pairs, where a cluster refers to a set of interconnected voxels each with test
statistics exceeding a certain threshold. Allowing for cluster-wise inference in
this way is an important advantage of this methodology over that proposed
by Stein et al. (2010) and Hibar et al. (2011), as the voxel-specific tests
proposed in the latter two articles might miss spatially extended signals that
do not achieve significance at any isolated voxel. In this sense Huang et al.
(2015) take advantage of the spatial information in the 3D images.
Ge et al. (2012) develop the first voxel-wise imaging genetics approach
that allows for interactions between genetic markers. At each voxel the au-
thors propose to fit a multi-locus model to associate the joint effect of several
SNPs with the imaging trait at that voxel. The imaging traits are similar
to those considered in Stein et al. (2010) though the model specified at
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each voxel is different. In particular, the semiparametric regression model
specified at each voxel takes the form
y`(v) = z
T
` β(v) + hv(x`) + e`(v), ` = 1, . . . , n,
where hv(x`) denotes a nonparametric function of the SNPs and the errors
are assumed to be normally distributed with mean 0 and standard deviation
σv. In this case the non-genetic covariates (e.g., age, gender, education,
handedness, and total intracranial volume) are modelled parametrically and
the effect of genetic markers is modelled nonparametrically using a least
squares kernel machines (Liu et al., 2007) approach. The function space
containing hv(·) is determined by an n× n kernel matrix which is a function
of the genetic data and must be positive definite. The (j, k) element of this
matrix is a function of the SNP genotypes of subjects j and k, and Ge et al.
(2012) specify the form of this kernel to be
k(xj,xk) =
1
2d
d∑
s=1
IBS(xjs, xks)
where IBS(xjs, xks) denotes the number of alleles shared identical by decent
by subjects j and k at SNP s and takes values 0, 1, or 2.
In this case the null hypothesis of interest is H0(v) : hv(·) = 0, which
examines the effect of multiple SNPs at each voxel. Importantly, the model
is very flexible and allows for interactions between the genetic markers. Ge
et al. (2012) exploit a connection between least squares kernel machines and
linear mixed models to derive a score statistic based on the null model (the
model with no SNPs) and argue that this statistic follows a mixture of chi-
squares under the null hypothesis. The score statistic has the advantage that
its computation does not require the estimation of the function h(·). Using
the Satterthwaite method, the distribution of this statistic under the null
hypothesis is approximated by a scaled chi-squared distribution.
Applying this technique at all voxels produces an image of score statistics
and the authors assume that this statistic image behaves like a χ2 random
field which facilitates inference using random field theory (Worsley, 1996).
Random field theory (RFT) produces FWE-corrected p-values for voxel-wise
and cluster-wise inference by accounting for the volume and smoothness of
the statistic image. As RFT requires fairly strong assumptions on the statis-
tic image and these assumptions may not be satisfied, the authors also de-
velop voxel-wise inference based on permutation procedures with a paramet-
ric tail approximation based on the Generalized Pareto Distribution.
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Along with allowing for interactions among genetic variables the work of
Ge et al. (2012) is the first to use RFT for inference in imaging genetics.
Thus while correlation across voxels is not accounted for directly within a
statistical model, the spatial structure of the imaging data is accounted for
when computing FWE-corrected p-values using RFT.
In a subsequent paper, Ge at al. (2015) extend the least squares kernel
machine approach of Ge et al. (2012) to allow for both interactions between
SNPs and further allow interactions between SNPs and non-genetic variables
such as disease risk factors, environmental exposures, and epi-genetic mark-
ers. The model specified is of the form
y`(v) = z
T
` β(v) + hv,x(x`) + hv,w(w`) + hv,x,w(x`,w`) + e`(v), ` = 1, . . . , n,
where z` are non-genetic variables with linear effect and w` are non-genetic
variables with nonlinear effect that may interact with the genetic markers. As
before a kernel machine based method is used to represent the nonparametric
effects. In their application, Ge at al. (2015) only consider a scalar phenotype
derived through MRI, namely, the hippocampal volume averaged between the
two brain hemispheres; however, combining the voxel-wise inference of Ge et
al. (2012) with the more flexible kernel machine model of Ge et al. (2015)
seems feasible for dealing with phenotypes comprising an entire 3D image.
The mass univariate and voxel-wise approaches are appealing because of
their simplicity and because the required univariate or multi-locus regression
models are relatively easy to fit. Modelling the dependence between different
voxels is avoided and this makes it feasible to perform large scale searches
across many voxels of an image. Despite these advantages an important
limitation is that these approaches do not exploit the spatial structure of
phenotype-genotype associations. If a particular SNP is related to one voxel
then it will likely be related to the neighbouring voxels as well, and these
approaches do not allow us to borrow strength across voxels. This borrow-
ing of strength can lead to higher power and is thus desired. Multivariate
approaches are thus natural to consider, but these models typically require
a significant reduction in the dimension of the neuroimaging phenotype by
two orders of magnitude.
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3 Multivariate Approaches
With multivariate approaches all of the neuroimaging phenotypes are in-
cluded in a single large model that may account for the dependence structure
across the different phenotypes while relating each of the phenotypes to all of
the genetic markers. As a result, these approaches are typically not applied
to imaging data at the voxel level as this is computationally intractable.
A multivariate approach is typically applied to images reduced to a much
coarser scale where each phenotype corresponds to a summary measure for
an ROI in the brain. Table 1 provides an example of such summary measures
for the 56 ROIs considered in our example.
In the work of Wang et al. (2012) an estimator based on group sparse
regularization is applied to multivariate regression for relating neuroimag-
ing phenotypes to SNPs, where the SNPs are grouped by genes and this
grouping structure is accounted for in the construction of the estimator. Let
y` = (y`1, . . . , y`c)
T denote the imaging phenotype summarizing the struc-
ture of the brain over c ROIs for subject `, ` = 1, . . . , n. The corresponding
genetic data are denoted by x` = (x`1, . . . , x`d)
T , ` = 1, . . . , n, where we
have information on d SNPs, and x`j ∈ {0, 1, 2} is the number of minor al-
leles for the jth SNP. We further assume that each SNP can be associated
with a gene so that the set of genes represents a higher level grouping of the
SNPs. Thus the set of SNPs can be partitioned into K genes, and we let
pik, k = 1, 2, . . . , K, denote the set containing the SNP indices corresponding
to the kth group and mk = |pik|. This partitioning is used to allow for gene-
wise association among SNPs. This is done through a regularization in which
the coefficients of the SNPs within a gene, with respect to all of the imaging
phenotypes, are penalized as a whole with an l2-norm, while the l1-norm is
used to sum up the gene-wise penalties to enforce sparsity between genes.
The latter is important because in reality only a small fraction of genotypes
are related to a specific phenotype.
It is assumed that E(y`) = W
Tx`, ` = 1, . . . , n, where W is a d x c
matrix, with each row characterizing the association between a given SNP
and the brain summary measures across all c ROIs. The estimator proposed
by Wang et al. (2012) takes the form
Wˆ = arg min
W
n∑
`=1
||WTx`-y`||22 +γ1||W||G2,1 + γ2||W||l2,1 (1)
where γ1 and γ2 are regularization parameters weighting a G2,1-norm penalty
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||W||G2,1 =
∑K
k=1
√∑
i∈pik
∑c
j=1w
2
ij and an `2,1-norm penalty ||W||l2,1 =∑d
i=1
√∑c
j=1w
2
ij respectively. The G2,1-norm encourages sparsity at the gene
level. This regularization differs from group lasso (Yuan and Lin, 2006) as
it penalizes regression coefficients for a group of SNPs across all imaging
phenotypes jointly. As an important gene may contain irrelevant individual
SNPs, or a less important group may contain individually significant SNPs,
the second penalty, an `2,1-norm (Evgeniou and Pontil, 2007), is added to
allow for additional structured sparsity at the level of SNPs (the rows of W).
The estimator (1) provides a novel approach for assessing associations
between neuroimaging phenotypes and genetic variations as it accounts for
several interrelated structures within genotyping and imaging data. Wang et
al. (2012) develop an optimization algorithm for the computation of (1) and
suggest the use of cross-validation for the selection of tuning parameters γ1
and γ2. A limitation of the proposed methodology is that it only furnishes
a point estimate Wˆ and techniques for obtaining valid standard errors or
interval estimates are not provided.
In recent work Greenlaw et al. (2017) address this limitation and extend
the methodology of Wang et al. (2012) so that the uncertainty associated
with Wˆ can be quantified, and their methodology allows for formal statistical
inference beyond the sparse point estimate Wˆ. Following the ideas of Park
and Casella (2008) and Kyung et al. (2010), Greenlaw et al. (2017) develop
a hierarchical Bayesian model that allows for full posterior inference. The
Bayesian model is constructed with a particular prior for W so that the
estimator (1) corresponds to the posterior mode. The spread of the posterior
distribution then provides valid measures of posterior variability along with
credible intervals for each regression parameter.
Let W(k) = (wij)i∈pik denote the mk × c submatrix of W containing the
rows corresponding to the kth gene, k = 1, . . . , K. The hierarchical model of
Greenlaw et al. (2017) corresponding to the estimator (1) takes the form
y` |W, σ2 ind∼ MVNc(W Tx` , σ2Ic), ` = 1, . . . , n, (2)
with the coefficients corresponding to different genes assumed conditionally
independent
W(k)|λ21, λ22, σ2 ind∼ p(W(k)|λ21, λ22, σ2) k = 1, . . . , K, (3)
and with the prior distribution for each W(k) having a density function given
14
by
p(W(k)|λ21, λ22, σ2) ∝ exp
−λ1σ
√√√√∑
i∈pik
c∑
j=1
w2ij

×
∏
i∈pik
exp
−λ2σ
√√√√ c∑
j=1
w2ij
 .
(4)
By construction, the posterior mode, conditional on λ21, λ
2
2, σ
2, corresponding
to the model hierarchy (2) - (4) is exactly the estimator (1) proposed by Wang
et al. (2012) with γ1 = 2σλ1 and γ2 = 2σλ2. This equivalence between the
posterior mode and the estimator of Wang et al. (2012) is the motivation for
the model; however, generalizations that allow for a more flexible covariance
structure in (2) can also be considered, and an extension of this model to
allow for spatial correlation is discussed in Section 6.
Greenlaw et al. (2017) develop a Gaussian scale mixture representation of
this hierarchical model which allows for the implementation of Bayesian infer-
ence using a straightforward Gibbs sampling algorithm that is implemented
in the R package ‘bgsmtr’ (Bayesian Group Sparse Multi-Task Regression)
which is available for download on CRAN (https://cran.r-project.org/
web/packages/bgsmtr/). The selection of the tuning parameters λ21 and λ
2
2
for this model is investigated in Nathoo et al. (2016), where selection of
these tuning parameters based on a fully Bayes approach with hyperpriors,
an empirical Bayes approach, and the WAIC are compared.
Vounou et al. (2010) propose an alternative strategy for multivariate
regression modelling with imaging genetics data where the high-dimensional
regression coefficient matrix is approximated by a low rank sparse matrix
leading to a sparse reduced rank regression (sRRR) model. Suppose that
X is the n × d design matrix of genetic markers and Y is the n × c matrix
of imaging phenotypes. Beginning with the standard multivariate multiple
linear regression model Y = XC+E, where C is the d×c matrix of regression
coefficients, the approach proceeds by first imposing a rank condition on this
matrix rank(C) ≤ min(d, c) which leads to a decrease in the number of
parameters that need to be estimated. In particular, if C has rank r then
it can be expressed as C = BA where B is d × r and A is r × c such
that rank(A) = rank(B) = r. The loss function for estimation is based on
the weighted least squares criterion M = Tr{(Y −XBA)Γ(Y −XBA)T},
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where Γ is a c × c positive definite weight matrix. Vounou et al. (2010)
consider sparse estimation of both B and A through penalized estimation
incorporating l1-norm penalties. In particular, setting Γ to be the identity
matrix we have
M = Tr{YYT} − 2Tr{AYTXB}+ Tr{AATBTB},
where the first term on the RHS can be ignored as it does not depend on B
or A. Assuming r = 1 and adding l1-norm penalization yields the following
optimization problem
arg min
a,b
{−2aYTXb + aaTbTb + λa||aT ||1 + λb||bT ||1}
where a is 1×c corresponding to the phenotypes and b is d×1 corresponding
to the genetic markers. The sparsity of the solution depends on the values
of λa and λb with the non-zero elements of aˆ selecting phenotypes and the
non-zero elements of bˆ selecting genetic markers.
The optimization problem is biconvex and Vounou et al. (2010) present
an iterative algorithm for solving it. After the rank-one solution has been
found, additional ranks can be obtained by applying the algorithm to the
residuals of the data matrices. Vounou et al. (2010) suggest a graphical
approach based on the residuals at each successive rank that can be used to
select an optimal rank. As with the Wang et al. (2012) methodology, the
methodology of Vounou et al. (2010) provides selection and point estimation
but does not provide any mechanism for uncertainty quantification. This
lack of uncertainty quantification can be a serious problem as we illustrate
in our example application of Section 5.
Zhu et al. (2014) develop a Bayesian reduced rank model for imaging ge-
netics that incorporates several enhancements above and beyond the method-
ology proposed in Vounou et al. (2010). First, the Bayesian approach enables
uncertainty quantification for the regression parameters based on the poste-
rior distribution. Second, in addition to reducing the dimension of the regres-
sion coefficient matrix with a low rank approximation, Zhu et al. (2014) also
incorporate a sparse latent factor model to represent the high-dimensional
covariance matrix of the brain imaging phenotypes, with a multiplicative
gamma process shrinkage prior assigned to the factor loadings.
As with Vounou et al. (2010) the proposed model is based on the mul-
tivariate linear model Y = XC + E, where E = (`k) and the rows of E,
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each corresponding to a different subject, are assumed independent with
` ∼ MVNc(0,Σ). The rank r decomposition of C with r << min(c, d)
takes the form C =
∑r
j=1 Cj =
∑r
j=1 δjujv
T
j , where Cj = δjujv
T
j is the
j-th layer, uj ∈ Rd and vj ∈ Rc. The regression errors for each subject are
expressed using a latent factor model ` = Λη` + ξ`, where Λ is a d × ∞
factor loading matrix, η` ∼ MVN∞(0, I∞), and ξ` ∼ MVNc(0,Σξ) with
Σξ = diag{σ21, . . . , σ2c}. While it is typical to set the dimension of the latent
factor η` to be much smaller than `, the approach followed in Zhu et al.
(2014) is to choose a multiplicative gamma process prior for Λ that shrinks
increasingly the elements to zero as the column index increases, thereby
avoiding the issue of choosing the number of factors (see also Bhattacharya
and Dunson, 2011). The overall model for the imaging phenotype for a given
subject can be written as
y` =
r∑
j=1
XT` δjujv
T
j + Λη` + ξ`,
and Gaussian shrinkage priors are adopted for δj, uj, and vj, j = 1, . . . , r.
Zhu et al. (2014) present a Gibbs sampler that can be used to sample the
posterior distribution and investigate a number of model selection criteria
for choosing r. Their simulation studies indicate that the BIC outperforms
several other model selection criteria in determining the true rank of C.
Overall, the use of multivariate methods over the mass univariate and
voxel-wise approaches can lead to greater efficiency through the borrowing
of information across related brain imaging phenotypes. The approach of
Wang et al. (2012) scales relatively well but does not provide uncertainty
quantification. The Bayesian model of Greenlaw et al. (2017) addresses
this issue at the expense of the greater computation required by the MCMC
algorithm. As a result, the approach does not scale as well as that of Wang
et al. (2012) and it requires parallel computation for the selection of tuning
parameters. The sRRR approach proposed by Vounou et al. (2010) allows
for potentially higher dimensional datasets with an appropriate choice of the
rank of the regression coefficient matrix, while the Bayesian reduced rank
approach of Zhu et al. (2014) offers several advantages including uncertainty
quantification and a sparse latent factor model for the covariance matrix of
the response. A disadvantage of the multivariate approaches, regardless of
which is chosen, is that the imaging data must be substantially reduced to
a summary measure over a reasonable number of ROIs (in the hundreds at
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most) while the mass univariate and voxel-wise approaches can be applied
to tens of thousands of voxels.
4 Methods for Longitudinal Imaging Genet-
ics Studies
Longitudinal imaging genetics studies such as the ADNI study can provide
insight into different rates of brain deterioration and how change in the struc-
ture of the brain over time is related to genetics. Szefer et al. (2017) have
recently considered a longitudinal analysis of the ADNI database examin-
ing 75, 845 SNPs in the Alzgene linkage regions and investigated associa-
tions with estimated rates of change in structural MRI measurements for
56 brain regions. Szefer et al. (2017) consider three phases of the ADNI
study in their analysis, ADNI-1, ADNIGO, and ADNI-2. More information
on the ADNI study including information on data access is available online
at http://adni.loni.usc.edu/about/. The regions considered in Szefer et
al. (2017) are the same as those considered in Greenlaw et al. (2017), and
also described in Table 1 which we consider in our example analysis of the
next session.
A primary innovation in the analysis of Szefer et al. (2017) is to construct
from longitudinal MRI data and linear mixed models a set of subject and
region specific rates of change over time. These estimated rates of change are
then related to genetic markers using sparse canonical correlation analysis.
Szefer et al. (2017) also use inverse probability weighting to account for
the biased sampling design of the ADNI study, an aspect that has not been
considered in many previous imaging genetics studies.
Let y`(t) = (y`1(t), . . . , y`c(t))
T denote the imaging phenotype summa-
rizing the structure of the brain over c ROIs for subject `, ` = 1, . . . , n, and
at time t, where, for the ADNI study considered by Szefer et al. (2017)
t ∈ {0, 6, 12, 18, 24} months following entry into the study. For the jth ROI,
Szefer et al. (2017) fit the following standard linear mixed model with ran-
dom intercept and slope for time
y`j(t) = β0j + β1jMCI + β2jAD + β3jt+ β4jMCI× t
+ β5jAD× t+ γ1`j + γ2`jt+ `j(t), (5)
where AD is an indicator for Alzheimer’s Disease, MCI is an indicator for mild
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cognitive impairment, the β terms denote fixed effects and the γ terms denote
random effects. The estimated rate of change extracted from the fitted linear
mixed model is βˆ3j + βˆ4jMCI + βˆ5jAD + γˆ2`j, and these estimates, which are
region specific, are used as the imaging phenotypes in the second stage of their
analysis after adjusting for population stratification using multidimensional
scaling. The genetic markers are also adjusted for population stratification
using the principal coordinates obtained from multidimensional scaling.
A sparse linear combination of the SNP genotypes that is most associated
with a linear combination of the imaging phenotypes (the estimated rates
of change) is obtained using sparse canonical correlation analysis (SCCA).
SCCA is a multivariate method for estimating maximally correlated sparse
linear combinations of the columns of two multivariate data sets. The degree
of sparsity in the coefficients of the genotypes is controlled by a regularization
parameter, and Szefer et al. (2017) choose this parameter so that approxi-
mately 10% of the SNPs have non-zero coefficients. A bootstrap procedure
is then used to estimate the relative importance of each SNP. In particular,
sampling with replacement within each disease category (MCI, AD, Cogni-
tively Normal), if βb = (β1b, . . . , βdb)
T denotes the coefficient vector of the
sparse linear combination of SNPs estimated from the bth bootstrap sample,
Szefer et al. (2017) define the importance probability for the kth SNP as
VIPk =
1
B
B∑
b=1
I{βkb = 0}
where B is the total number of bootstrap samples. These importance prob-
abilities are then used to select important subsets of SNPs. An interesting
aspect of the analysis performed by Szefer et al. (2017) is that their proce-
dure is applied to an ADNI-1 training sample to obtain subsets of important
SNPs, and the authors are then able to validate many of these priority SNPs
using a validation set from ADNIGO/2.
An alternative model for longitudinal imaging genetics data has been
proposed recently by Lu et al. (2017). The proposed model extends the
Bayesian low rank model of Zhu et al. (2014) to the longitudinal setting.
Unlike the two-stage longitudinal analysis of Szefer et al. (2017), the model
of Lu et al. (2017) links the time-varying neuroimaging data directly to
the genetic markers in a single model that includes the data from all ROIs.
Moreover, the proposed model allows for gene-age interactions so that the
genetic effects on ROI volumes can vary across time.
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Letting y`j(t) denote the longitudinal imaging measure obtained from
subject ` at ROI j and time t, the model takes the form
y`j(t) = X
T
` βj+µj(t)+w`(t)
Tγk+z`(t)
Tb`j+`j(t), ` = 1, . . . , n; j = 1, . . . c,
where X` contains the genetic markers; w`(t) is a vector of time-varying
covariates that may include interactions between genetic markers and time;
µj(t) is an overall temporal trend for the j
th ROI; and b`j is a vector of subject
specific Gaussian random effects for ROI j corresponding to covariates z`(t).
Lu et al. (2017) represent the functions µj(t) using penalized-splines, and
as in Zhu et al. (2014) a low rank approximation is used to approximate
the regression coefficient matrix. The errors `j(t) are represented through a
sparse factor model
`j(t) = Λη`(t) + ξ`(t)
with priors similar to those adopted in Zhu et al. (2014), including a multi-
plicative gamma process prior for Λ. A Gibbs sampling algorithm is used to
implement Bayesian inference.
Overall, methods for longitudinal imaging genetics studies are just in
their infancy, with very few published papers developing statistical methods
to date. We believe there is significant scope for new work in this sub-area.
Regarding the methods discussed here, a primary difference in the work of Lu
et al. (2017) and that proposed by Szefer et al. (2017) is that the regression
model on genetic markers in the latter case is built on estimated rates of
change of the ROI volumes; whereas, Lu et al. (2017) link the genetic data
directly to the mean of the ROI volumes. Both methods provide useful and
complimentary techniques for analyzing longitudinal imaging genetics data.
5 Example Application
We provide an example application examining an imaging genetics dataset
obtained from the ADNI-1 database. The analysis presented here is consid-
ered in greater detail in Greenlaw et al. (2017); however, our objective in
this case is simply to provide the reader with a simple example illustrating
the use of some of the methods discussed in our review.
The dataset includes both genetic and structural MRI data, the latter
leading to the 56 imaging phenotypes presented in Table 1. The data are
available for n = 632 subjects (179 cognitively normal, 144 Alzheimer’s,
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309 mild cognitive impairment), and among all possible SNPs the analysis
includes only those SNPs belonging to the top 40 Alzheimer’s Disease (AD)
candidate genes listed on the AlzGene database as of June 10, 2010. The
data presented here are queried from the most recent genome build as of
December 2014, from the ADNI-1 data.
After quality control and imputation steps, the genetic data used for
this study includes 486 SNPs from 33 genes and these genes along with the
distribution of the number of SNPs within each gene is depicted in Figure 1.
The freely available software package PLINK (Purcell et al., 2007) was used
for genomic quality control. Thresholds used for SNP and subject exclusion
were the same as in Wang et al. (2012), with the following exceptions. For
SNPs, we required a more conservative genotyping call rate of at least 95%
(Ge et al., 2012). For subjects, we required at least one baseline and one
follow-up MRI scan and excluded multivariate outliers. Sporadically missing
genotypes at SNPs in the HapMap3 reference panel (Gibbs et al., 2003) were
imputed into the data using IMPUTE2 (Howie et al., 2009). Further details
of the quality control and imputation procedure can be found in Szefer (2016).
The MRI data from the ADNI-1 database are preprocessed using the
FreeSurfer V4 software which conducts automated parcellation to define vol-
umetric and cortical thickness values from the c = 56 brain regions of interest
that are detailed in Table 1. Each of the response variables are adjusted for
age, gender, education, handedness, and baseline total intracranial volume
(ICV) based on regression weights from healthy controls and are then scaled
and centered to have zero-sample-mean and unit-sample-variance.
We fit the Bayesian model of Greenlaw et al. (2017) and also compute the
group sparse multi-task regression and feature selection estimator of Wang et
al. (2012), both of which contain 56 × 486 = 27, 216 regression parameters.
For the former approach, we select potentially important SNPs by evaluating
the 95% equal-tail credible interval for each regression coefficient and select
those SNPs where at least one of the associated credible intervals excludes
0. In total there are 45 SNPs and 152 regression coefficients for which this
occurs. The 45 selected SNPs and the corresponding brain regions at which
we see a potential association based on the 95% credible intervals are listed
in Table 2.
Three SNPs, rs4311 from the ACE gene, rs405509 from the APOE gene,
and rs10787010 from the SORCS1 gene stand out as being potentially as-
sociated with the largest number of ROIs. The 95% credible intervals for
the coefficients relating rs4311 to each of the c = 56 imaging measures are
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depicted in Figure 2. Both the Bayesian posterior mean and the estimator
of Wang et al. (2012) are indicated in the figure.
In the original methodology of Wang et al. (2012) the authors suggest
ranking and selecting SNPs by constructing a SNP weight based on the point
estimate Wˆ and a sum of the absolute values of the estimated coefficients of
each single SNP over all of the tasks. Doing so, the top 45 highest ranked
SNPs contain 21 of the SNPs chosen using the Bayesian approach of Greenlaw
et al. (2017) and these 21 SNPs are highlighted in Table 2 with bold font.
The number 1 ranked (highest priority) SNP using this approach is SNP
rs3026841 from gene ECE1. In Figure 3 we display the corresponding point
estimates for this SNP along with the 95% credible intervals obtained from
the Greenlaw et al. (2017) Bayesian approach, where again the credible
intervals and point estimates are relating this SNP to each of the c = 56
imaging measures. Importantly, we note that all 56 of the corresponding
95% credible intervals include the value 0.
This result demonstrates the importance of accounting for posterior un-
certainty beyond a sparse point estimate and illustrates the potential prob-
lems that may arise when estimation uncertainty is ignored, as in the ap-
proach of Wang et al. (2012). The methodology of Greenlaw et al. (2017)
compliments the estimator of Wang et al. (2012) by providing uncertainty
quantification, and both approaches may be applied together for such anal-
yses.
While we have focussed on uncertainty quantification using credible inter-
vals, the posterior distribution can be summarized through posterior prob-
abilities of the form Pr(|Wij| > δ|Data) for known critical value δ > 0, or
through kernel density estimation of the posterior density for certain regres-
sion coefficients. In the former case, adjustments for multiplicity can be made
using Bayesian FDR procedures (Morris et al., 2008).
6 DISCUSSION
Imaging genetics is an emerging discipline that is based on combining two
of the most important scientific fields where statistical research has made a
major impact, genetics and neuroimaging. The resulting studies provide a
number of big data challenges for statistical analysis. We have reviewed a
variety of approaches for the analysis of such data focussing on mass uni-
variate and voxel-wise approaches, multivariate approaches, and methods for
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longitudinal studies. Figure 5 summarizes these three approaches from a
graphical perspective.
One class of methods that we have not discussed in our review is the class
of predictive methods for imaging genetics. In this setting the dependent
variable is a condition or health outcome (such as presence of Alzheimer’s
disease), and the imaging and genetic data are used as features for clas-
sification. These methods typically aim at detecting prognostic markers.
Typically, regularization methods, boosting algorithms and deep learning
methods are applied to such problems (see e.g., Wang et al. 2012; Zhang et
al. 2014). Within a Bayesian setting, a predictive model for imaging genet-
ics with application to schizophrenia has been developed by Chekouo et al.
(2016).
While our review is not an exhaustive review of existing methods for
imaging genetics, our aim was to provide the reader with a sample of the
existing work and a flavour of the challenges for data analysis in this area.
Indeed, this is a relatively new area in statistics and there is much scope for
improving the existing methods.
For example, one current avenue of interest is the extension of the method-
ology developed by Greenlaw et al. (2017) to accommodate a more realistic
covariance structure for the imaging phenotypes. One approach for doing this
is through a sparse latent factor model as considered in Zhu et al. (2014)
and Lu et al. (2017). An alternative approach that we are currently inves-
tigating is the use of spatial models based on Markov random fields for the
regression errors. More specifically, for the data considered in Greenlaw et al.
(2017), our example in Section 5, and described in Table 1, the MRI-based
phenotypes will exhibit two forms of correlation: (1) spatial correlation be-
tween neighbouring ROIs on the same brain hemisphere; and (2) correlation
between corresponding measures on opposite brain hemispheres (e.g., the
volume of the left hippocampus will be highly correlated with the volume of
the right hippocampus).
Considering the model formulation of Greenlaw et al. (2017), we begin
by rearranging the imaging phenotypes so that they occur in left-right pairs
in the vector y` ∈ Rc. Let y`,i = (y(L)`,i , y(R)`,i )T be the brain summary measures
obtained at the ith ROI for both the left and right hemispheres. Then y` =
(yT`,1, . . . ,y
T
`, c
2
)T is the imaging phenotype for subject ` with the elements
rearranged so that left-right pairs are adjacent. The regression model is
specified as y` = W
Tx` + e` where a spatial model for e` is based on a
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proper bivariate conditional autoregressive model (Gelfand and Vounatsou,
2013).
We assume A is an adjacency matrix Aij ∈ {0, 1} representing the
spatial neighbourhood structure of ROIs on each hemisphere, with DA =
diag{Ai·, i = 1, ..., c/2}. The conditional specification for the regression er-
rors is given by
e`,i|{e`,j, j 6= i}, ρ,Σ ∼ BVN( ρ
Ai·
c/2∑
j=1
Aije`,j,
1
Ai·
Σ), i = 1, . . . , c/2,
where ρ ∈ [0, 1) characterizes spatial dependence and Σ12/
√
Σ11Σ22 ∈ [−1, 1]
characterizes the dependence in the phenotypes across opposite hemispheres
of the brain.
The first level of the model can then be expressed as
y`|W, ρ,Σ ind∼ MVNc(WTx` , (DA − ρA)−1 ⊗ Σ), ` = 1, . . . , n
with higher levels of the model including the shrinkage prior for W specified
as in Greenlaw et al. (2017) with some minor modifications. To clarify, the
neighborhood structure and resulting adjacency matrix is used in the model
to represent spatial dependence between phenotypes on the same hemisphere
of the brain, while Σ, a 2-by-2 matrix, is used to represent the correlation
between the same phenotype on opposite hemispheres of the brain. For
specification of such a model it is convenient to arrange the phenotypes into
left-right pairs which is why the rearrangement is needed.
With regards to computation for this model, Greenlaw et al. (2017) and
the corresponding R package ’bgsmtr’ make use of sparse numerical linear
algebra routines as the full conditional distributions for W have sparse pre-
cision matrices under that model. This is essential in order for the Gibbs
sampling algorithm to be scalable to imaging genetics data of even moder-
ately large size. In the proposed spatial model, so long as the adjacency
matrix A is sparse the model structure still results in sparse precision matri-
ces where required for faster computation. This is an advantage of using the
Markov random field model over some other possible spatial models. The
additional parameters ρ ∼ Unif(0, 1) and Σ ∼ inv-Wishart(S, ν) are easily
added to the existing the Gibbs sampling algorithm. In addition to the use
of Gibbs sampling, we are also developing a mean-field variational Bayes al-
gorithm (see e.g., Nathoo et al., 2014) for the same model which should allow
24
for greater scalability. We hope to report on results from this new model in-
cluding a comparison of the different algorithms for Bayesian computation in
a follow-up paper. The algorithms for fitting the new model will be available
in the next version of the ’bgsmtr’ R package.
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Table 1: Imaging phenotypes defined as volumetric or cortical thickness
measures of 28×2 = 56 ROIs from automated Freesurfer parcellations. Each
of the phenotypes in the table corresponds to two phenotypes in the data:
one for the left hemisphere and the other for the right hemisphere.
ID Measurement Region of interest
AmygVol Volume Amygdala
CerebCtx Volume Cerebral cortex
CerebWM Volume Cerebral white matter
HippVol Volume Hippocampus
InfLatVent Volume Inferior lateral ventricle
LatVent Volume Lateral ventricle
EntCtx Thickness Entorhinal cortex
Fusiform Thickness Fusiform gyrus
InfParietal Thickness Inferior parietal gyrus
InfTemporal Thickness Inferior temporal gyrus
MidTemporal Thickness Middle temporal gyrus
Parahipp Thickness Parahippocampal gyrus
PostCing Thickness Posterior cingulate
Postcentral Thickness Postcentral gyrus
Precentral Thickness Precentral gyurs
Precuneus Thickness Precuneus
SupFrontal Thickness Superior frontal gyrus
SupParietal Thickness Superior parietal gyrus
SupTemporal Thickness Superior temporal gyrus
Supramarg Thickness Supramarginal gyrus
TemporalPole Thickness Temporal pole
MeanCing Mean thickness Caudal anterior cingulate, isthmus cingulate,
posterior cingulate, rostral anterior cingulate
MeanFront Mean thickness Caudal midfrontal
rostral midfrontal, superior frontal
lateral orbitofrontal, and medial orbitofrontal gyri
frontal pole
MeanLatTemp Mean thickness Inferior temporal, middle temporal
superior temporal gyri
MeanMedTemp Mean thickness Fusiform, parahippocampal, and lingual gyri,
temporal pole and transverse temporal pole
MeanPar Mean thickness Inferior and superior parietal gyri
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ID Measurement Region of interest
supramarginal gyrus, and precuneus
MeanSensMotor Mean thickness Precentral and postcentral gyri
MeanTemp Mean thickness Inferior temporal, middle temporal, superior temporal,
fusiform, parahippocampal, lingual gyri, temporal pole,
transverse temporal pole
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Table 2: The 45 SNPs selected from the Bayesian model along with cor-
responding phenotypes where (L), (R), (L,R) denote that the phenotypes
are on the left, right, and both hemispheres respectively. SNPs also ranked
among the top 45 using the Wang et al. (2012) estimate are listed in bold.
SNP Gene Phenotype ID (Hemisphere)
rs4305 ACE LatVent (R)
rs4311 ACE InfParietal (L,R)
MeanPar (L,R), Precuneus (L,R)
SupParietal (L), SupTemporal (L)
CerebCtx (R), MeanFront (R)
MeanSensMotor (R), MeanTemp (R)
Postcentral (R), PostCing (R)
Precentral (R), SupFrontal (R)
SupParietal (R)
rs405509 APOE AmygVol (L), CerebWM (L), Fusiform (L)
HippVol (L), InfParietal (L,R),SupFrontal (L,R), Supramarg (L,R)
InfTemporal (L), MeanFront (L,R), MeanLatTemp (L,R)
MeanMedTemp (L,R), MeanPar (L,R),
MeanSensMotor (L,R), MeanTemp (L,R)
MidTemporal (L,R), Postcentral (L,R), Precuneus (L,R)
SupTemporal (L,R), Precentral (R), SupParietal (R)
rs11191692 CALHM1 EntCtx (L)
rs3811450 CHRNB2 Precuneus (R)
rs9314349 CLU Parahipp (L)
rs2025935 CR1 CerebWM (R), Fusiform (R), InfLatVent (R)
rs11141918 DAPK1 CerebCtx (R)
rs1473180 DAPK1 CerebCtx (L,R) ,EntCtx (L), Fusiform (L)
MeanMedTemp (L), MeanTemp (L), PostCing (L)
rs17399090 DAPK1 MeanCing (R), PostCing (R)
rs3095747 DAPK1 InfLatVent (R)
rs3118846 DAPK1 InfParietal (R)
rs3124237 DAPK1 PostCing (R), Precuneus (R), SupFrontal (R)
rs4878117 DAPK1 MeanSensMotor (R), Postcentral (R)
rs212539 ECE1 PostCing (R)
rs6584307 ENTPD7 Parahipp (L)
rs11601726 GAB2 CerebWM (L), LatVent (L)
rs16924159 IL33 MeanCing (L), PostCing (L), CerebWM (R)
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SNP Gene Phenotype ID (Hemisphere)
rs928413 IL33 InfLatVent (R)
rs1433099 LDLR CerebCtx.adj (L), Precuneus (L,R)
rs2569537 LDLR CerebWM (L,R)
rs12209631 NEDD9 CerebCtx (L), HippVol (L,R)
rs1475345 NEDD9 Parahipp (L)
rs17496723 NEDD9 Supramarg (L)
rs2327389 NEDD9 AmygVol (L)
rs744970 NEDD9 MeanFront (L), SupFrontal (L)
rs7938033 PICALM EntCtx (R), HippVol (R)
rs2756271 PRNP EntCtx (L), HippVol (L,R), InfTemporal (L), Parahipp (L)
rs6107516 PRNP MidTemporal (L,R)
rs1023024 SORCS1 MeanSensMotor (L), Precentral (L)
rs10787010 SORCS1 AmygVol (L), EntCtx (L,R)
MeanFront (L), Fusiform (L)
HippVol (L,R), InfLatVent (L), InfTemporal (L)
MeanMedTemp (L,R), MeanTemp (L)
Precentral (L), TemporalPole (R)
rs10787011 SORCS1 EntCtx (L,R), HippVol(R)
rs12248379 SORCS1 PostCing (R)
rs1269918 SORCS1 CerebCtx (L), CerebWM (L), InfLatVent (L)
rs1556758 SORCS1 SupParietal (L)
rs2149196 SORCS1 MeanSensMotor (L), Postcentral (L,R)
rs2418811 SORCS1 CerebWM (L,R), InfLatVent.adj (L)
rs10502262 SORL1 MeanCing (L), InfTemporal (R), Supramarg (R)
rs1699102 SORL1 MeanMedTemp (R), MeanTemp (R)
rs1699105 SORL1 MeanCing (L), Precuneus (L)
rs4935774 SORL1 CerebWM (L,R)
rs666004 SORL1 InfTemporal (L)
rs1568400 THRA Precentral (L), TemporalPole (R)
rs3744805 THRA MeanSensMotor (R), Postcentral (R), Precentral (R)
rs7219773 TNK1 MeanSensMotor (L), Precentral (L), Postcentral (R)
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Low Dimensional Representations
!  A low dimensional representation is necessary for statistical inference 
!  Whole brain tractography is complicated
(1) Connectivity matrix (2) Fiber bundles
versions of the tract. The second row shows the different candidates for
this tract in the same test subject, based on using each atlas to decide
which fibers it should contain (Distance-based clustering section). The
final result for this tract was obtained by applying the label fusion
scheme in Fiber label fusion section. It is not hard to see that the label
fusion process can help to eliminate outliers, and it can also addmissing
fibers to a single candidate labeling of the tract. A manually edited
segmentation result is also included for comparison (see the right
bottom panel).
Figs. 6 and 7 show the label fusion results for the 17 segmented
tracts in four randomly selected subjects. Despite individual variations,
the overall tract shapes are consistent across the population. Fig. 8
shows the combined WM fiber clustering results for the four test sub-
jects. The types of tracts and their colors are as in Fig. 2. The average
fiber number in our full set of clustering results is ~40,000 per subject,
or roughly 1/10th of the fibers from the initial tractography. There are
three factors that affect howmanyfibers are included in thefinal results.
First, in this work, we mainly focused on 17 major anatomically well-
known white matter tracts. Therefore, only those tracts are shown in
Fig. 8. Many other less-known tracts are not shown and could be
added in future work, although it might be more challenging to reliably
find smaller tracts in the mix of all the other major pathways. Second,
streamline whole-brain tractography generates large numbers of false
positive fibers and those need to be removed for our ultimate goal –
population studies. Last, fiber clusteringmay show enormous individual
variation when applied across a population. However, to perform an
effective population study, we only included fibers whose shape shares
the most common characteristics throughout the population for each
tract. This was our intent when we built our manually constructed
atlases. Clearly we would need to admit that some clinically interesting
variation is missed by focusing on a set of standard tracts. But finding
additional consistent tracts across subjects is challenging and runs the
risk of including false positives.
Quantitative validation
To quantitatively evaluate the proposed framework, we converted
each of the fiber tracts to a binary image, where voxels that the tracts
cross were marked as 1, and 0 otherwise. Then we used the Dice
coefficient to assessing the overlap or agreement between two tracts,
defined as:
D a; bð Þ ¼ 2 $ V að Þ∩V bð Þð Þ
V að Þ þ V bð Þ ð6Þ
where V() is the volume of the region that the tract penetrates.
Due to thewide variability between different tracts, we need to tune
the parameters of our algorithm to optimize its performance. We have
two key parameters to adjust. One is the Hausdorff distance threshold
used to select fibers for each tract per atlas (dcutoff in Eq. (4)), and the
other is the percentage of fibers included in the final label fusion stage
described in Fiber label fusion section.
Fig. 8. Back, left side, and bottom views of the same four subjects' (in Figs. 6 and 7) compositional fiber clustering results are shown. The original whole-brain tractography (the leftmost
column) is included for comparison, clearly showing the utility of the data reduction.
Table 1
The values of the clustering distance threshold and the fusion percentage for each tract described in Tract atlas construction section that were used to cluster the 198 subjects in our data set.
Tract name L/R-ATR L/R-CGC L/R-CST L/R-IFO L/R-ILF L-ARC CC-FRN CC-PRC CC-POC CC-PAR CC-TEM CC-OCC
d cutoff
mmð Þ
12 12 12 12 12 12 12 12 12 12 12 12
Fusion pct. (%) 100 85 95 95 70 95 90 95 100 95 45 100
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Figure 1: Selected Imaging Phenotypes (IPs)
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Figure 2: Each of the 33 genes partitioning the 486 SNPs included in the
example data analysis of Section 5.
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Figure 3: The 95% equal-tail credible intervals relating the SNP rs4311 from
ACE to each of the c = 56 imaging phenotypes. Each imaging phenotype
is represented on the x-axis with a tick mark and these are ordered in the
same order as the phenotypes are listed in the rows of Table 1, first for
the left hemisphere and then followed by the same phenotypes for the right
hemisphere.
37
Figure 4: The 95% equal-tail credible intervals relating the SNP rs3026841
from ECE1 to each of the c = 56 imaging phenotypes. Each imaging pheno-
type is represented on the x-axis with a tick mark and these are ordered in
the same order as the phenotypes are listed in the rows of Table 1, first for
the left hemisphere and then followed by the same phenotypes for the right
hemisphere.
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Figure 5: The three approaches discussed in the paper summarized from a
graphical perspective: (a) mass univariate and voxel-wise approaches; (b)
multivariate approaches; (c) methods for longitudinal imaging genetics stud-
ies.
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